In studies designed to elucidate the problem of the fate of dehydroascorbic acid in guinea pigs, Gould & Shwachman (1943) found that oral or injected solutions of ascorbic acid, which had undergone oxidation by treatment with iodine, exerted an antiscorbutic effect. Penney & Zilva (1943) and Damron, Monier & Roe (1952) , using solutions of ascorbic acid oxidized by potassium iodate and bromine respectively, found that single injections of dehydroascorbic acid were partly reduced to ascorbic acid and partly oxidized to diketogulonic acid.
To human subjects Johnson & Zilva (1934) gave oral solutions of dehydroascorbic acid prepared by iodine and hydrogen peroxide oxidation of lemon juice; Todhunter, McMillan & Ehmke (1950) administered orally solutions containing dehydroascorbic acid prepared by charcoal treatment of orange juice, while de Ritter, Cohen & Rubin (1951) gave dehydroascorbic acid or its methanolate by mouth. From the effects on plasma concentration or urinary output or both, these investigators concluded that oral dehydroascorbic acid has the same effect as ascorbic acid. We are not aware of any experiments in which dehydroascorbic acid has been injected into human subjects.
Additional interest in dehydroascorbic acid was stimulated by the suggestion of Long, Miles & Perry (1951) based on the modification of tuberculin sensitivity in guinea pigs, that adrenocorticotrophic hormone and cortisone exert their beneficial actions by facilitating conversion of ascorbic acid into dehydroascorbic acid.
Therefore, when relatively pure preparations of dehydroascorbic acid became available, it was decided to study the degree of its reduction to ascorbic acid when administered orally or by injection to guinea pigs and to human subjects and whether adrenocorticotrophic hormone (ACTH) or cortisone would inhibit this reduction. The possible effects of adrenocorticotrophic hormone and cortisone favouring the oxidation of injected ascorbic acid were also studied.
MATERIALS AND METHODS
Dehydroascorbic acid (sample A, Boots Pure Drug Co. Ltd.). This was supplied as a yellow powder containing 80% of the acid, 0-8% ascorbic acid, no diketogulonic acid and unknown impurities. This sample was considered unsuitable for injection into human subjects. It was used for injection into some guinea pigs and for oral administration to two human volunteers (subjects 1 and 2).
Dehydroascorbic acid methanolate (sample B, Roche Products Ltd.). This was prepared by the method of Pecherer (1951) and was used for other experiments. The colourless crystals were readily soluble in water and promptly dissociated to dehydroascorbic acid and methanol. No adverse effects were observed from the small amount of methanol given (which was 15% of the dose of dehydroascorbic acid). All doses of dehydroascorbic acid are expressed in mg. of the acid. When fresh, dehydroascorbic acid methanolate was 98 % pure but, on storage for approximately 2 years, the purity decreased to 66 %; at this stage it contained 4% diketogulonic acid. The fresh material was used for injection into human subjects and the stored material for injection into some guinea pigs with due allowance for the decrease in dehydroascorbic content; the quantity of diketogulonic acid injected was too small to influence our results. (A possible exception is the urinary excretion of R & K material (for definition see this page) by guinea pig Z, which was injected with large quantities of this sample, containing approximately 6 mg./day of diketogulonic acid.) The methanolate contained no ascorbic acid. Intramuscular injections into humans ofthis sample of dehydroascorbic acid were so painful that the solutions were mixed with 4% (w/v) procaine (0.25 vol.) immediately before injection; assay of the stability of dehydroascorbic acid in procaine in vitro showed a loss of 2 % in 1 hr. Where ascorbic acid was injected intramuscularly for control periods it was mixed with the same proportion of 4% procaine.
Ascorbic acid. This was administered to human subjects as tablets by the oral and in saline solution by intravenous or intramuscular routes; for guinea pigs it was dissolved in water before injection. Sodium ascorbate was prepared by almost neutralizing ascorbic acid with 9 % (w/v) NaOH or 1-85% (w/v) NaHCO8 immediately before administration, and was used in some investigations because preliminary experiments had suggested that it caused less tissue necrosis than the free acid and might therefore be more regularly absorbed; subsequently it became clear that the rates of absorption were indistinguishable.
Hormone Chemical determination of ascorbic acid, dehydroascorbic acid and diketogulonic acid. Ascorbic acid was determined by titration with 2:6-dichlorophenolindophenol (dye); since this titration measures unidentified material present in urine in addition to ascorbic acid, the formaldehyde correction procedure (McSwiney, Clayton & Prunty, 1954) was applied to all human urines except those ofsubjects 1 and 2. Application of this formaldehyde procedure to several hundred samples of guinea pig urine showed a nearly constant output of 0 3-0-6 mg./day of impurities (in terms of ascorbic acid), and the results with this method, in the case of guinea pigs, have been omitted in this report. Ascorbic acid proved stable in liver filtrates; in adrenal filtrate, however, there was a disappearance of approximately 10% in 2 hr. and adrenal filtrates were therefore titrated with dye within a few minutes of preparation.
Dehydroascorbic acid in biological material was determined by H2S treatment followed by titration with dye. The dinitrophenylhydrazine method of Roe & Kuether (1943) , as modified by Geschwind, Williams & Li (1951) was used for the determination of ascorbic+ dehydroascorbic ± diketogulonic acids; since this method may also measure unidentified impurities (Penney & Zilva, 1945) , the group of substances measured by this technique will be referred to as R & K material and expressed as ascorbic acid.
Assays of purity of dehydroascorbic acid. Assays were carried out by both the dinitrophenylhydrazine method, and by reduction with H2S at pH 3-5 followed by titration with iodine (Kenyon & Munro, 1948) or dye.
Sterilization of dehydroascorbic acid solution8. For injection into human subjects solutions were sterilized by filtration through sintered glass of porosity 3. Assays of solutions before and after filtration showed no change in dehydroascorbic acid concentration and the solutions were sterile on culture.
Treatment of guinea pig8 and analysis of tissues. Guinea pigs were brought into the laboratory several days before use and were maintained on a diet free from ascorbic acid (Harris & Ray, 1932 Tissue analy8is. Preliminary experiments indicated that killing by stunning and bleeding gave more regular results than death by decapitation, ether, Nembutal (Abbott Laboratories Ltd.) or coal gas. They also showed that rapidity of technique was essential at all stages. When each guinea pig was killed the adrenal glands and liver were dissected out rapidly, placed in tared vessels containing sand and 10-l ml. or 50-0 ml. respectively of 5% (w/v) where the dose of dehydroascorbic acid was twice the dose of ascorbic acid, the tissue levels were similar and there was no significant difference in the ratios of ascorbic acid/R & K material.
Effects of ACTH and cortisone Long-term experiments. Groups of guinea pigs were depleted for 12 days and then injected with dehydroascorbic acid or ascorbic acid for 3 days with or without administration of cortisone acetate or ACTH. The administration of ACTH and cortisone acetate was begun 24 hr. before that of ascorbic or dehydroascorbic acid. The results are shown in Table 3 . No condition in this experiment favoured either the formation or persistence of dehydroascorbic acid, since none of the' ratios of ascorbic acid/R & K material were significantly changed in adrenals or liver as a result of treatment; for significance with these numbers of degrees of freedom, t must be greater than 2. In addition, the total amount of R & K material accumulating in the livers following treatment with ascorbic or dehydroascorbic acid was not significantly changed.
Short-term experiments. For 3-5 days before ACTH treatment, healthy guinea pigs were placed on the scorbutic diet supplemented by 100 g. cabbage daily. On the day of the experiment no cabbage was given. Groups 1-7 (Table 4) received no ascorbic acid by injection. Groups 3-7 received an intraperitoneal injection of ACTH and were killed at intervals up to 4 hr. thereafter. Groups 8-16 were given one subcutaneous injection of ascorbic acid or sodium ascorbate combined, in groups 11, 12, 15 and 16, with a simultaneous subcutaneous injection of ACTH. Animals were killed 2 and 6 hr. later. Detailed results, shown in Table 4 , indicate that there was no significant change in the ratio of ascorbic acid/R & K material as a result of ACTH injection. There is a significant fall in both ascorbic acid and R & K material (P<0 05). No change occurred in the ratio in the liver ofanimals in groups 6 and 7.
Urinary excretion products of dehydroascorbic acid. Guinea pigs used weighed 470-600 g. Guinea pig G (Table 5 ) was maintained on the scorbutic diet supplemented by ascorbic acid for days 1 to 7. On days 8 to 16, ascorbic acid was replaced by the same dosage of dehydroascorbic acid. On days 17 and 18 the same dose of dehydroascorbic acid was injected subcutaneously and the animal died during day 18. Results show that this large oral dose of ascorbic acid gave minimal excretion of ascorbic acid, dehydroascorbic acid and R & K material in the urine; with dehydroascorbic acid given orally the excretion of all three increased but still remained only a small fraction of the total dose; with injected dehydroascorbic acid, the urinary excretion of ascorbic acid and R & K material showed a more marked increase.
Two guiniea pigs, B and C, on the scorbutic diet were given courses of ascorbic acid and dehydroascorbic acid (sample A) by subcutaneous injection of 5 mg./100 g. body weight twice daily; control courses with a nil intake were included for comparison; the products excreted in urine were measured. The effect of ACTH injections during a course of dehydroascorbic acid were also studied. The results for guinea pig C are summarized in Fig. 1 . The other animal gave an identical response. When The dehydroascorbic acid output in urine showed no significant change throughout and is therefore not shown. ACTH does not appear to influence the products excreted in urine during a course of dehydroascorbic acid. In guinea pig Z subcutaneous injections of ascorbic acid (5 mg./100 g. body weight twice daily) were followed by subcutaneous injections of dehydroascorbic acid (14 mg./100 g. body weight twice daily; sample B). The output of ascorbic acid in urine averaged 4 1 and 2-7 mg./day respectively, while the R & K material averaged 4-4 and 6-1 mg./ day.
The fate of dehydroascorbic acid in human subjects Oral administration. After a course of ascorbic acid (600 mg./day in divided doses) sufficiently long to give a regular excretion of ascorbic acid, two normal human subjects (both male, aged 25) were given dehydroascorbic acid (sample A) for 4 and 5 days respectively. Then both were given ascorbic acid for a further control period. In subject 1 it was not realized at the time that the preparation of dehydroascorbic acid was only 80% pure, so that the effective dose was 480 mg./day; the ascorbic acid output (on dehydroascorbic acid) showed a fall consistent with this decrease in dosage. In subject 2 the effective dose was 600 mg./day, and there was no significant change in ascorbic acid output (Fig. 2) ascorbic acid were given after 6 days on a normal diet when she was moderately depleted of ascorbic acid. Results are given in Table 7 . When dehydroascorbic acid was injected the urine ascorbic acid gradually rose to a stable value: R & K material, on the other hand, rose promptly. The plasma ascorbic acid also increased. On days 13 to 15 ACTH was also injected. The urinary output of ascorbic acid and R & K material showed little change, but the urinary dehydroascorbic acid was markedly increased.
In subject 5 (female, aged 39, rheumatoid arthritis) (Fig. 3) the effect of ACTH was studied during a course of dehydroascorbic acid. Ascorbic acid was given orally on days 1 to 6 in order to saturate the patient, and was followed by intramuscularly injected dehydroascorbic acid in four doses of 100 mg. daily. During the course of dehydroascorbic acid alone the output ofmetabolites became stable (days 18 to 22), the amounts in mg./day being: ascorbic acid, 105 ± 6; dehydroascorbic acid, 4*2 ± 1-3; R & K material, 276 ± 25. The effect of ACTH (days 23 to 27) was a brief rise in urinary ascorbic acid and R & K material; the plasma levels showed no significant change in ascorbic acid but an increase in R & K material.
Intravenou8 adminiatration. A single intravenous injection of dehydroascorbic acid was given to subject 6 (male, aged 44, rheumatoid arthritis) who was receiving for therapeutic purposes 100 mg. of cortisone acetate daily, and the effect of dehydroascorbic acid was compared with that of ascorbic acid in the same dose given 3 days later (Fig. 4) . After dehydroascorbic acid the plasma ascorbic acid and R & K material increased, but the rise was smaller than after ascorbic acid; the difference between plasma ascorbic acid and R & K material increased slightly on both occasions. Plasma dehydroascorbic acid, after both injections, showed only small irregular changes.
Effect of ACITH on metaboli8m of dehydroascorbic acid given intravenously In subject 7 (female, aged 34, lupus erythematosus) advantage was taken of the intravenous route in an attempt to demonstrate whether ACTH injections might result in a persistence of dehydro-
ascorbic acid; such a persistence should result in an increase in plasma or urinary dehydroascorbic acid.
In order to raise the plasma and urine concentration of ascorbic acid and R & K material to levels at which they could be determined with accuracy, ascorbic acid was given daily in 50 mg. oral doses at 5, 7 and 10 p.m. throughout the investigation. After 11 days for equilibration, a single intravenous injection of 180 mg. of dehydroascorbic acid was given at 10 a.m. on day 12. After 4 days, to permit changes in ascorbic acid saturation to subside, dehydroascorbic acid was injected at 11 a.m., 1 hr. after intramuscular injection of 100 i.u. ACTH in saline; for therapeutic purposes 50 i.u. of ACTH in VoI. 58 5.49 . /0 saline were given at 5 p.m., 10 p.m., 4 a.m. and 10 a.m. daily through the remainder of this investigation. A third injection of dehydroascorbic acid was given on day 20 at 11 a.m., 1 hr. after 50 i.u. of ACTH. Plasma concentration of ascorbic acid, dehydroascorbic acid and R & KEmaterialwere determined immediately before and 1, 2 and 4 hr. after each injection of dehydroascorbic acid (Fig. 5) ; the ascorbic acid level increased to approximately the same degree on all three occasions, indicating some reduction of the intravenous dehydroascorbic acid. ACTH did not significantly affect the amount of dehydroascorbic acid or the ratio of ascorbic acid/R & K material. Excretion of ascorbic acid, dehydroascorbic acid and R & K material is shown in Table 8 . The first injection of dehydroascorbic acid, on day 12, was followed by an increased excretion of 32 mg. of ascorbic acid and 101 mg. of R & K material as compared with the average for days 10 and 11. Comparison of days 16 and 12 indicates a significantly increased excretion of R & K material minus ascorbic acid after the first injection of ACTH.
DISCUSSION
Metaboliwm of dehydroa8corbic acid The antiscorbutic effect of dehydroascrobic acid when administered to guinea pigs either orally or by injection confirms the findings of earlier workers using oxidized ascorbic acid solutions. By injection, as little as 2 mg. daily was sufficient to prevent the onset of scurvy and to permit continued growth. By feeding, this was insufficient to allow continued gain in weight. That dehydroascorbic acid is readily reduced after injection into the guinea pig is also demonstrated by its uptake as ascorbic acid in the tissues. Thus 40 mg. daily for 3 days were sufficient to raise the heavily depleted adrenal and liver ascorbic acid to nearly normal levels, although the experimental conditions were deliberately chosen to avoid the supersaturation period after giving a dose (Penney & Zilva, 1946) . The injection of 10 mg. dehydroascorbic acid failed to raise the tissue level to normal. This dosage was also too small to cause a significant excretion of ascorbic acid or R & K material in urine and, since the whole normal animal would not contain more than 8 mg. of ascorbic acid, an appreciable portion must have been destroyed. It did not persist as dehydroascorbic acid in the tissues and it was not present as an oxidation product recognizable by the Roe & Kuether procedure. Damron et al. (1952) , using a different method, concluded that at most only trace amounts of dehydroascorbic acid were present in normal tissues; Penney & Zilva (1943) found none. Oxidation may proceed further to oxalate and carbon dioxide (Burns, Burch & King, 1951) .
In the guinea pig, after injection of dehydroascorbic acid, only small amounts of excretory products were detected and dehydroascorbic acid was not present in the urine in detectable amounts. When equal doses of ascorbic and dehydroascorbic acids were compared, the latter led to the excretion of much less ascorbic acid and much more R & K material minus ascorbic acid. This tendency was also observed in the human subjects. When dehydroascorbic acid was injected into an individual unsaturated with ascorbic acid, the excretion of R & K material minus ascorbic acid was high for the first few days, but it was several days before the ascorbic acid in urine rose sharply. This also suggests that the oxidation products of dehydroascorbic acid are taken up by the unsaturated organism to a much smaller degree (ifat all) than the ascorbic acid formed by reduction in the body. This finding was also confirmed after intravenous administration of dehydroascorbic acid to the more nearly saturated subject 7.
After injection of dehydroascorbic acid intramuscularly or intravenously there is a temporary rise in the plasma ascorbic acid level and a tendency to an even greater increase in the R & K material minus ascorbic acid (Figs. 4 and 5) . Plasma dehydroascorbic acid, on the other hand, followed the same trend as the ascorbic acid. It must be concluded that injected dehydroascorbic acid is partly reduced to ascorbic acid but that a greater proportion is oxidized to products estimated by the Roe & Kuether method. It does not tend to persist as dehydroascorbic acid. Comparison of results with orally administered dehydroascorbic acid with those from injection experiments shows interesting differences. In the guinea pig dehydroascorbic acid given orally is partially reduced to ascorbic acid as evidenced by its antiscorbutic properties, although large amounts lead to the excretion of only miniimal amounts of ascorbic acid or R & K material. This is in agreement with the results of Penney & Zilva (1943 , 1946 , who demonstrated reduction of dehydroascorbic acid in the stomach wall; absorption of ascorbic acid in the stomach was poor and destruction of it took place in the more alkaline small intestine. In the human, on the other hand, absorption is better and appears as good as that of ascorbic acid (Fig. 2) . The fact that the same dose of ascorbic and dehydroascorbic acid given orally in the human leads to excretion of similar amounts ofascorbic acid in the urine suggests that the latter is almost quantitatively reduced to ascorbic acid. This is in accord with the results of Johnson & Zilva (1934) , Todhunter et al. (1950) and de Ritter et al. (1951) . The reduction of dehydroascorbic acid by the oral route is somewhat better than after injection, when a smaller amount of ascorbic acid is excreted in urine after a dose of dehydroascorbic acid than after an equivalent dose of ascorbic acid. It is possible that bacterial reduction may play some part in the intestinal conversion of dehydroascorbic acid into ascorbic acid (Mapson & Ingram, 1951) .
In the experiments in which tissue levels of ascorbic acid were studied in guinea pigs after injection of dehydroascorbic acid 2 to 3 times as much dehydroascorbic acid was required to raise the tissue concentration of ascorbic acid to the level produced by a given amount of ascorbic acid. When the antiscorbutic activity is considered, 2 mg. daily of dehydroascorbic acid is less effective by injection than 2 mg. of ascorbic acid. In both the guinea pig and man approximately 3 times as much dehydroascorbic acid as ascorbic acid had to be injected to produce a similar excretion of ascorbic acid (guinea pig Z and Table 6 ).
Caution should be adopted with the injection of dehydroascorbic acid into human subjects. Apart from the complaints by the patients of local pain, the liver and epidermal changes in the guinea pig are of special note. These appeared to be caused by dehydroascorbic acid or by some impurity only present in very small amounts, since they were observed with both samples of dehydroascorbic acid. It is possible that the toxic effects of dehydroascorbic acid in the guinea pig may be due to decreased ability of this animal to reduce the acid, even though the reduction is sufficient to give tissue levels of ascorbic acid incompatible with the development of scurvy. The ultimate cause of the toxicity is not at present known.
Effect8 of ACTH and corti8one on dehydroa8corbic acid metabolism In guinea pigs we failed to observe any change in ascorbic or dehydroascorbic acid metabolism when ACTH or cortisone acetate were given. This was even true when conditions of possible utilization of ascorbic acid in the adrenal were chosen, i.e. during the fall occurring in the few hours immediately after ACTH injection (Long, 1947) . Neither in this shortterm experiment nor the longer one lasting over 3 days was there a significant fall in liver ascorbic acid concentration such as that observed by Harris, Bland, Huglhes & Constable (1953) . It is possible that even in the longer experiment the duration of ACTH or cortisone administration was too short.
The rise in excretion of ascorbic acid and R & K material when ACTH and ascorbic acid was administered, observed by McSwiney et al. (1954) , was probably not seen because the period of observation was too short. In the human subjects ACTH produced more definite changes. In the excretion pattern in subject 5 there was a transitory increase in ascorbic acid and R & K material minus ascorbic acid, but the ratio of ascorbic acid/R & K remained virtually unaltered, as it did in the experiments employing ascorbic acid (McSwiney et al. 1954 ). However, the sharp rise in urinary R & K material minus ascorbic acid observed when intravenous dehydroascorbic acid and ACTH were given together must be noted (Table 8) . Another subject (Table 7) excreted small but significantly increased amounts of dehydroascorbic acid in the urine when this acid and ACTH were given. ACTH caused a similar increase in dehydroascorbic acid in one subject receiving ascorbic acid (McSwiney et al. 1954 ). In two instances there was a fall in the plasma ascorbic acid/R & K ratio (Table 7 and Fig. 3 ). This effect, too, may be observed in the experiments of McSwiney et al. (1954) . We have never seen a plasma ascorbic acid/R & K ratio approximating to 1>0 as reported by Stewart, Horn & Robson (1953) . These authors found the change occurred within 4 hours of the injection of ACTH or oral administration of cortisone acetate, whereas our observations were made over a period of several days. It may be concluded that ACTH does not apparently regularly and significantly retard the reduction of dehydroascorbic to ascorbic acid and this is especially true in the guinea pig experiments. 
